Taysha Gene Therapies, Inc. (TSHA)
NASDAQ·Healthcare·Biotechnology
$6.30
-2.55%
Mkt Cap $1.60B
Analyst Ratings
Buy
7
Hold
0
Sell
0
Price Target (15 analysts)
$11.13
Range $8.00 – $13.00
Implied Upside
+76.8%
Consensus $11.13 vs current $6.30
NASDAQ·Healthcare·Biotechnology
$6.30
-2.55%
Mkt Cap $1.60B
Buy
7
Hold
0
Sell
0
Price Target (15 analysts)
$11.13
Range $8.00 – $13.00
+76.8%
Consensus $11.13 vs current $6.30